Health Care & Life Sciences » Pharmaceuticals | BAFNA Pharmaceuticals Ltd.

BAFNA Pharmaceuticals Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
24,912.00
62,133.40
153,191.70
203,627.30
-
-
Depreciation, Depletion & Amortization
89,938.40
59,854.70
48,586.00
42,195.00
-
-
Other Funds
500.00
-
-
-
-
-
Funds from Operations
95,208.40
356,979.10
120,510.70
170,976.80
129,352.00
-
Changes in Working Capital
207,679.00
332,708.10
3,943.10
16,119.50
-
-
Net Operating Cash Flow
112,470.60
24,271.00
116,567.50
187,096.40
-
-
Capital Expenditures
17,526.60
77,898.70
23,069.50
790.60
-
Sale of Fixed Assets & Businesses
-
411,107.50
-
-
-
Purchase/Sale of Investments
-
150,938.20
-
-
-
Net Investing Cash Flow
70,676.30
597,573.20
7,500.90
8,693.50
-
Issuance/Reduction of Debt, Net
-
404,661.80
123,504.40
137,843.60
-
Net Financing Cash Flow
500.00
573,661.80
123,504.40
177,843.60
-
Net Change in Cash
182,646.90
359.60
564.10
559.20
-
Free Cash Flow
129,997.20
102,169.70
139,637.00
187,886.90
-
Other Sources
14,942.00
113,426.20
15,905.00
9,544.50
-
Change in Capital Stock
-
169,000.00
-
40,000.00
-
Other Uses
68,091.70
-
336.40
60.40
-

About BAFNA Pharmaceuticals

View Profile
Address
Bafna Towers
Chennai Tamil Nadu 600001
India
Employees -
Website http://www.bafnapharma.com
Updated 07/08/2019
Bafna Pharmaceuticals Ltd. is engaged in the manufacture of drugs and medicines of life saving drugs. Its brand portfolio includes Raricap, Raricap Forte, Raricap L Suspension and Raricap Combi. The company was founded in 1981 and is headquartered in Chennai, India.